ACR and acute myeloid leukemia: However, with 3-week post-injection of GCSF into AML- (AML + GCSF), CYT- (CYT + GCSF) and (AML + CYT)- (AML + CYT + GCSF) treated mice there was a significant increase in the percentage of tubules with 10 ACROSIN-stained cells/tubule and in the expression levels of ACROSIN in their testicular tissue compared to AML- and (AML + CYT)-, but not to CYT-treated mice (Figure 5D,D1).